Učitavanje...
New Cancer Drugs at the Cost of Bankruptcy: Will the Oncologist Tell the Patients the Benefit in Terms of Days/Weeks Added to Life?
In addition to considerations of possible cancer treatments reducing quality of life, the cost effectiveness of such treatments must also be a factor when determining treatments. Some patients have opted for expensive new treatments, leading to high financial risk but only modest results. Oncologist...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4257748/ https://ncbi.nlm.nih.gov/pubmed/25480341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0263 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|